CEM Executive and Leadership Team

Brian Chin, the Chief Executive Officer at CEM, directs the overarching strategic vision for laboratory instrumentation development. Chin architects long-term growth initiatives by aligning manufacturing capabilities with evolving scientific research requirements. Overseeing the integration of advanced technology into product design, the Chief Executive Officer ensures that all laboratory equipment meets rigorous global standards. This leadership role involves constant collaboration with the board to maintain market competitiveness across North American and international sectors. By prioritizing operational efficiency, Brian Chin drives the company toward sustained innovation in scientific methodology. The Chief Executive Officer monitors performance metrics to guarantee that every product line supports the core mission of providing reliable, high-precision tools for modern laboratories. Through this focused approach, Chin secures the company position as a leader in the scientific equipment manufacturing industry, consistently delivering value to stakeholders while fostering a culture of technical excellence and precision engineering.

Maddie Harwood, the President & Chief Executive Officer at CEM, manages the daily execution of corporate strategy and organizational development. Harwood drives the expansion of scientific instrumentation portfolios by identifying emerging market opportunities in the global research sector. Overseeing cross-functional teams, the President & Chief Executive Officer ensures that product development cycles remain agile and responsive to client needs. This leadership role requires constant engagement with technical departments to maintain the high quality of laboratory equipment manufactured at the headquarters. By optimizing internal processes, Maddie Harwood improves overall productivity and supports the company commitment to scientific advancement. The President & Chief Executive Officer coordinates with other senior leaders to align resource allocation with strategic goals, ensuring that the organization remains at the forefront of laboratory technology. Through disciplined management, Harwood strengthens the market presence of the company, delivering consistent results that reflect a dedication to precision and innovation in every scientific instrument produced.

Danil Abdulla, the Chairman and CEO at CEM, governs the high-level strategic direction and corporate governance of the organization. Abdulla architects the long-term roadmap for scientific method development, ensuring that the company maintains a competitive edge in the laboratory instrumentation market. Overseeing board relations and investor communications, the Chairman and CEO provides the necessary stability for sustained growth. This leadership role involves evaluating macro-economic trends to guide the company through complex global market shifts. By fostering a culture of rigorous scientific inquiry, Danil Abdulla drives the development of next-generation laboratory tools that define industry standards. The Chairman and CEO monitors the alignment of corporate objectives with the mission of providing superior analytical solutions to researchers worldwide. Through strategic oversight, Abdulla ensures that the organization remains focused on its core competencies, consistently delivering high-performance equipment that supports the advancement of scientific knowledge and laboratory efficiency across diverse international markets.

James Fonseca, the Chief Financial Officer at CEM, directs all fiscal planning, budgeting, and financial reporting activities. Fonseca architects the financial strategy to support the manufacturing of laboratory instrumentation, ensuring that capital allocation aligns with research and development priorities. Overseeing the financial health of the organization, the Chief Financial Officer manages risk assessment and compliance across all operational regions. This leadership role involves providing data-driven insights to the executive team to facilitate informed decision-making regarding market expansion and product investment. By optimizing the cost structure of manufacturing processes, James Fonseca improves profitability and supports the long-term sustainability of the company. The Chief Financial Officer maintains strong relationships with financial institutions to secure the resources necessary for ongoing innovation. Through meticulous financial management, Fonseca ensures that the company possesses the liquidity and stability required to lead the scientific equipment industry while delivering consistent value to shareholders and supporting the broader mission of scientific advancement.

Howard Fitch, the Chief Financial Officer & Co-Founder at CEM, oversees the foundational financial architecture and long-term capital strategy of the company. Fitch directs the management of corporate assets, ensuring that the manufacturing of laboratory instrumentation remains financially viable and scalable. Overseeing the integration of historical financial data with future growth projections, the Chief Financial Officer & Co-Founder provides the strategic framework for sustainable development. This leadership role involves balancing the needs of current operations with the requirements for future technological investments. By maintaining a focus on fiscal discipline, Howard Fitch supports the company mission of delivering high-quality scientific tools to a global research audience. The Chief Financial Officer & Co-Founder collaborates with the executive team to ensure that financial resources are directed toward the most impactful research and development projects. Through this dedicated oversight, Fitch secures the financial legacy of the company, ensuring that the organization continues to innovate and thrive within the competitive scientific equipment manufacturing sector.

Kelley Milsop, the President at CEM, directs the operational execution of the company business model, focusing on the manufacturing and distribution of laboratory instrumentation. Milsop architects the workflows that connect product design with market delivery, ensuring that every scientific instrument meets the highest quality standards. Overseeing the daily operations of the manufacturing facilities, the President ensures that production targets align with global demand. This leadership role involves coordinating between departments to streamline the supply chain and improve operational efficiency. By fostering a culture of continuous improvement, Kelley Milsop drives the company toward greater productivity and market responsiveness. The President monitors performance across all operational units to ensure that the organization remains agile in the face of changing scientific requirements. Through hands-on management, Milsop strengthens the operational foundation of the company, ensuring that the business consistently delivers reliable, high-precision laboratory solutions that empower researchers to achieve their scientific goals effectively and efficiently.

Shala Craig, the President & Senior Technical Director at CEM, directs the technical innovation and product development lifecycle for all laboratory instrumentation. Craig architects the scientific methods that underpin the company product line, ensuring that every piece of equipment provides accurate and reliable data for researchers. Overseeing the engineering and research teams, the President & Senior Technical Director ensures that technical advancements remain at the cutting edge of the industry. This leadership role involves translating complex scientific requirements into scalable manufacturing solutions. By bridging the gap between laboratory needs and industrial production, Shala Craig drives the company toward superior product performance. The President & Senior Technical Director collaborates with other executives to align technical roadmaps with overall corporate strategy. Through this technical leadership, Craig ensures that the company maintains its reputation for excellence in scientific instrumentation, consistently delivering innovative tools that solve critical challenges for laboratories across the global scientific community.